Significance of TP53 Mutational Status-Associated Signature in the Progression and Prognosis of Endometrial Carcinoma

Table 1

The baseline information of the EC patients.

Characteristic	TCGA (529)	ucec_tcga_pan_can_atlas_2018 (527)	ucec_tcga_pub (331)	Clinical specimens (60)
Age (years)
≤60	202	204	119	20
>60	324	321	212	40
None	3	2	0	0
BMI
≤24	69	65	59	11
>24	430	433	261	49
None	30	29	11	0
Grade
G1/2	215	215	169	35
G3	305	301	155	25
None	9	11	7	0
Stage
I/II	381	377	239	38
III/IV	148	150	92	22
None		0	0	0
TP53
Mut	204	192	103	24
Wild	325	335	228	36
None	0	0	0	0
Event
Alive	444	441	280	33
Dead	83	84	51	27
None	2	2	0	0